APA (7th ed.) Citation

Walter-Croneck, A., Grzasko, N., Soroka-Wojtaszko, M., Jurczyszyn, A., Torosian, T., Rymko, M., . . . Gawron, L. (2014). Case-adjusted bortezomib-based strategy in routine therapy of relapsed/refractory multiple myeloma shown to be highly effective—A report by Polish Myeloma Study Group. Leukemia Research, 38(7), 788. https://doi.org/10.1016/j.leukres.2014.04.011

Chicago Style (17th ed.) Citation

Walter-Croneck, Adam, et al. "Case-adjusted Bortezomib-based Strategy in Routine Therapy of Relapsed/refractory Multiple Myeloma Shown to Be Highly Effective—A Report by Polish Myeloma Study Group." Leukemia Research 38, no. 7 (2014): 788. https://doi.org/10.1016/j.leukres.2014.04.011.

MLA (9th ed.) Citation

Walter-Croneck, Adam, et al. "Case-adjusted Bortezomib-based Strategy in Routine Therapy of Relapsed/refractory Multiple Myeloma Shown to Be Highly Effective—A Report by Polish Myeloma Study Group." Leukemia Research, vol. 38, no. 7, 2014, p. 788, https://doi.org/10.1016/j.leukres.2014.04.011.